title: [Effects of oral cadmium exposure on expression of metallothionein-I and metallothionein-II mRNA in rat prostate].
abstract: OBJECTIVE
  To investigate the possible effects of oral cadmium(Cd) exposure on the expression levels of metallothionein-I and metallothionein-II (MT-I and MT-II) mRNA and the distribution of zinc (Zn) and Cd in rat prostate.
  
  
  METHODS
  Cadmium was given to rats at doses of 50, 100, and 200 mg/kg in drinking water. The contents of Zn and Cd in prostate were measured by atomic absorption spectrometry(AAS), and the levels of MTs mRNA were determined by RT-PCR.
  
  
  RESULTS
  After Cd administration, the content of Zn was decreased in both the ventral and the dorsolateral lobes of rat prostate. In 200 mg/kg Cd group, the contents of Zn in ventral prostate were 9.5 and 8.5 micrograms/g wet weight respectively after one month and six months, which were significantly lower than those of control(17.0 and 18.9 micrograms/g wet weight). In contrast, the contents of Cd in both ventral and dorsolateral lobes of prostate significantly increased with the increasing dose and time of Cd administration. It was also noted that Cd administration resulted in a significant down-regulation of the expression of MT-I and MT-II mRNA in rat ventral prostate. In 200 mg/kg Cd group after one and six months, the relative expression levels of MT-I (0.410, 0.339 respectively) and MT-II (0.100, 0.112 respectively) were significantly lower than those of MT-I (0.760, 0.830 respectively) and MT-II (0.429, 0.439 respectively) in control group.
  
  
  CONCLUSIONS
  Oral Cd exposure could influence the distribution of Zn and the expression levels of MTs mRNA in rat prostate.
authors.affiliation: Department of Occupational Health, School of Public Health, Fudan University, Shanghai 200032, China.
authors.forename: Xiangbin
authors.initials: X
authors.lastname: Zeng
authors.forename: Taiyi
authors.initials: T
authors.lastname: Jin
authors.forename: Yuanfen
authors.initials: Y
authors.lastname: Zhou
mesh_terms: D000284:Administration, Oral; D000818:Animals; D002104:Cadmium / Q000378:metabolism / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D008297:Male; D008668:Metallothionein / Q000235:genetics*; D011467:Prostate / Q000187:drug effects* / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis*; D051381:Rats; D015032:Zinc / Q000378:metabolism
chemical_list: C491055:Mt2A protein, rat; D012333:RNA, Messenger; D002104:Cadmium; D008668:Metallothionein; D015032:Zinc